Annual SGA
$24.44 M
+$1.94 M+8.60%
December 31, 2022
Summary
- As of February 10, 2025, TCRR annual SGA is $24.44 million, with the most recent change of +$1.94 million (+8.60%) on December 31, 2022.
- During the last 3 years, TCRR annual SGA has risen by +$10.54 million (+75.90%).
Performance
TCRR SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly SGA
$8.20 M
+$2.40 M+41.32%
March 31, 2023
Summary
- As of February 10, 2025, TCRR quarterly SGA is $8.20 million, with the most recent change of +$2.40 million (+41.32%) on March 31, 2023.
- Over the past year, TCRR quarterly SGA has increased by +$1.88 million (+29.76%).
Performance
TCRR Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM SGA
-$1.89 B
-$163.10 M-9.42%
March 31, 2023
Summary
- As of February 10, 2025, TCRR TTM SGA is -$1.89 billion, with the most recent change of -$163.10 million (-9.42%) on March 31, 2023.
- Over the past year, TCRR TTM SGA has dropped by -$1.92 billion (-8280.40%).
Performance
TCRR TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
TCRR Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.6% | +29.8% | -8280.4% |
| 3 y3 years | +75.9% | +92.0% | -10000.0% |
| 5 y5 years | +576.8% | +572.2% | -10000.0% |
TCRR Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -7.9% | at high | -36.5% | +53.0% | at low |
| 5 y | 5-year | at high | -43.1% | at high | -53.6% | +190.0% | at low |
| alltime | all time | at high | -90.8% | at high | -85.1% | +7095.6% | at low |
TCR2 Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $8.20 M(+41.3%) | $26.32 M(+7.7%) |
| Dec 2022 | $24.44 M(+8.6%) | $5.80 M(-8.1%) | $24.44 M(+2.5%) |
| Sep 2022 | - | $6.31 M(+5.1%) | $23.84 M(+1.5%) |
| Jun 2022 | - | $6.00 M(-5.0%) | $23.49 M(+1.5%) |
| Mar 2022 | - | $6.32 M(+21.4%) | $23.16 M(+2.9%) |
| Dec 2021 | $22.50 M(+34.6%) | $5.21 M(-12.7%) | $22.50 M(+4.3%) |
| Sep 2021 | - | $5.96 M(+5.2%) | $21.57 M(+8.0%) |
| Jun 2021 | - | $5.67 M(-0.0%) | $19.97 M(+10.3%) |
| Mar 2021 | - | $5.67 M(+32.8%) | $18.12 M(+8.4%) |
| Dec 2020 | $16.72 M | $4.27 M(-2.3%) | $16.72 M(+0.5%) |
| Sep 2020 | - | $4.37 M(+14.8%) | $16.63 M(+5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $3.81 M(-10.8%) | $15.78 M(+3.3%) |
| Mar 2020 | - | $4.27 M(+2.2%) | $15.28 M(+10.0%) |
| Dec 2019 | $13.89 M(+104.9%) | $4.18 M(+18.7%) | $13.89 M(+16.4%) |
| Sep 2019 | - | $3.52 M(+6.5%) | $11.94 M(+18.0%) |
| Jun 2019 | - | $3.31 M(+14.6%) | $10.12 M(+19.8%) |
| Mar 2019 | - | $2.89 M(+29.9%) | $8.45 M(+24.6%) |
| Dec 2018 | $6.78 M(+87.8%) | $2.22 M(+30.4%) | $6.78 M(+15.9%) |
| Sep 2018 | - | $1.70 M(+4.3%) | $5.85 M(+41.1%) |
| Jun 2018 | - | $1.63 M(+33.9%) | $4.14 M(+65.1%) |
| Mar 2018 | - | $1.22 M(-5.4%) | $2.51 M(+94.6%) |
| Dec 2017 | $3.61 M(+59.8%) | $1.29 M | $1.29 M |
| Dec 2016 | $2.26 M | - | - |
FAQ
- What is TCR2 Therapeutics annual SGA?
- What is the all time high annual SGA for TCR2 Therapeutics?
- What is TCR2 Therapeutics annual SGA year-on-year change?
- What is TCR2 Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for TCR2 Therapeutics?
- What is TCR2 Therapeutics quarterly SGA year-on-year change?
- What is TCR2 Therapeutics TTM SGA?
- What is the all time high TTM SGA for TCR2 Therapeutics?
- What is TCR2 Therapeutics TTM SGA year-on-year change?
What is TCR2 Therapeutics annual SGA?
The current annual SGA of TCRR is $24.44 M
What is the all time high annual SGA for TCR2 Therapeutics?
TCR2 Therapeutics all-time high annual SGA is $24.44 M
What is TCR2 Therapeutics annual SGA year-on-year change?
Over the past year, TCRR annual SGA has changed by +$1.94 M (+8.60%)
What is TCR2 Therapeutics quarterly SGA?
The current quarterly SGA of TCRR is $8.20 M
What is the all time high quarterly SGA for TCR2 Therapeutics?
TCR2 Therapeutics all-time high quarterly SGA is $8.20 M
What is TCR2 Therapeutics quarterly SGA year-on-year change?
Over the past year, TCRR quarterly SGA has changed by +$1.88 M (+29.76%)
What is TCR2 Therapeutics TTM SGA?
The current TTM SGA of TCRR is -$1.89 B
What is the all time high TTM SGA for TCR2 Therapeutics?
TCR2 Therapeutics all-time high TTM SGA is -$26.32 M
What is TCR2 Therapeutics TTM SGA year-on-year change?
Over the past year, TCRR TTM SGA has changed by -$1.92 B (-8280.40%)